{
    "id": "22759eaf-980b-4683-abbf-317e56323541",
    "indications": {
        "text": "sucralfate oral suspension indicated short-term ( 8weeks ) treatment active duodenal ulcer .",
        "doid_entities": [
            {
                "text": "duodenal ulcer (DOID:1724)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1724"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "recommended adult oral duodenal ulcer 1 gram ( 10 ml ) four times per day . sucralfate oral suspension administered empty stomach . antacids may prescribed needed relief pain taken within one-half hour sucralfate oral suspension . healing sucralfate may occur first week two , treatment continued 4 8 weeks unless healing demonstrated x-ray endoscopic examination .",
        "doid_entities": [
            {
                "text": "duodenal ulcer (DOID:1724)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1724"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "sucralfate oral suspension , 1 g/10 ml pink suspension cherry flavor supplied following forms : ndc 0904-7470-66 : 10 ml unit dose cup . case contains 20 unit-dose cups 10 ml ( ndc 0904-7470-56 ) , packaged 2 trays 10 unit-dose cups , 30 unit-dose cups 10 ml ( 0904-7470-01 ) , packaged 3 trays 10 unit-dose cups , 40 unit-dose cups 10 ml ( ndc 0904-7470-18 ) , packaged 4 trays 10-unit-dose cups , 50 unit-dose cups 10 ml ( ndc 0904-7470-95 ) , packaged 5 trays 10 unit-dose cups 100 unit-dose cups 10 ml ( ndc 0904-7470-72 ) , packaged 10 trays 10 unit-dose cups . shake well using . avoid freezing . store controlled room temperature 20\u00ba 25\u00bac ( 68\u00ba 77\u00baf ) ; excursions permitted 15\u00ba 30\u00bac ( 59\u00ba 86\u00baf ) . [ usp controlled room temperature ] . rx distributed : major\u00ae pharmaceuticals indianapolis , 46268 r02/24",
    "adverseReactions": "sucralfate oral suspension contraindicated patients known hypersensitivity active substance excipients .",
    "ingredients": [
        {
            "name": "SUCRALFATE",
            "code": "XX73205DH5",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9313"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX",
            "drugbank_id": "https://go.drugbank.com/drugs/DB09462"
        },
        {
            "name": "METHYLCELLULOSE, UNSPECIFIED",
            "code": "Z944H5SN0H",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11228"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31835"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "DIMETHICONE",
            "code": "92RU3N3Y1O",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11074"
        },
        {
            "name": "SORBITOL",
            "code": "506T60A25R",
            "drugbank_id": "https://go.drugbank.com/drugs/DB01638"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        }
    ],
    "organization": "Major Pharmaceuticals",
    "name": "Sucralfate",
    "effectiveTime": "20250502",
    "indications_original": "Sucralfate Oral Suspension is indicated in the short-term (up to 8weeks) treatment of active duodenal ulcer.",
    "contraindications_original": "The recommended adult oral dosage for duodenal ulcer is 1 gram (10 mL) four times per day. Sucralfate Oral Suspension should be administered on an empty stomach.\n                        Antacids may be prescribed as needed for relief of pain but should not be taken within one-half hour before or after Sucralfate Oral Suspension.\n                        While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination.",
    "warningsAndPrecautions_original": "Sucralfate Oral Suspension, 1 g/10 mL is a pink suspension with cherry flavor supplied in the following dosage forms:\n                  NDC 0904-7470-66: 10 mL unit dose cup.\u00a0 Case contains 20 unit-dose cups of 10 mL (NDC 0904-7470-56), packaged in 2 trays of 10 unit-dose cups each, 30 unit-dose cups of 10 mL (0904-7470-01), packaged in 3 trays of 10 unit-dose cups each, 40 unit-dose cups of 10 mL (NDC 0904-7470-18), packaged in 4 trays of 10-unit-dose cups each, 50 unit-dose cups of 10 mL (NDC 0904-7470-95), packaged in 5 trays of 10 unit-dose cups each and 100 unit-dose cups of 10 mL (NDC 0904-7470-72), packaged in 10 trays of 10 unit-dose cups each.\n                  \n                     SHAKE WELL BEFORE USING.\u00a0 AVOID FREEZING.\n                  \n                  Store at controlled room temperature 20\u00ba to 25\u00baC (68\u00ba to 77\u00baF); excursions permitted between 15\u00ba to 30\u00baC (59\u00ba to 86\u00baF).\u00a0 [See USP Controlled Room Temperature].\n                  Rx Only\n                  \n                     Distributed by:\n                     \n                     MAJOR\u00ae PHARMACEUTICALS\n                     Indianapolis, IN\u00a0 46268\n                  \n                     \u00a0\n                  \n                  \n                     R02/24",
    "adverseReactions_original": "Sucralfate Oral Suspension is contraindicated for patients with known hypersensitivity reactions to the active substance or to any of the excipients.",
    "drug": [
        {
            "name": "Sucralfate",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9313"
        }
    ]
}